Overview

Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis

Status:
Recruiting

Trial end date:
2022-11-15

Target enrollment:

Participant gender:

Summary

This research is being done to evaluate whether combining medications that are FDA approved, but have not yet been approved for combination treatment, can be effective in reducing pain.

Phase:

Phase 2

Details

Lead Sponsor:

Johns Hopkins University

Collaborator:

National Institutes of Health (NIH)

Treatments:

Central Nervous System Stimulants